iDose TR: The Future of Glaucoma Treatment

What is iDose TR?

iDose TR is an innovative, sustained-release intraocular implant designed to deliver a continuous, therapeutic dose of medication directly to the eye. It is developed to treat patients with open-angle glaucoma or ocular hypertension, offering a potential alternative to daily eye drops.

How Does iDose TR Work?

The iDose TR implant is filled with travoprost, a medication commonly used to lower intraocular pressure (IOP). It is inserted into the eye through a minimally invasive procedure and is designed to continuously release the medication over an extended period.

Key Features:

• Sustained Release: Provides continuous delivery of medication for up to a year.
• Minimally Invasive: The implant is inserted through a micro-invasive procedure.
• Biocompatibility: Made from materials that are safe and well-tolerated by the eye.

Benefits of iDose TR

• Improved Compliance: Reduces the burden of daily eye drop regimens.
• Consistent IOP Control: Offers steady medication levels, potentially reducing fluctuations in IOP.
• Patient Convenience: Eliminates the need for frequent dosing, enhancing the quality of life.

Clinical Trials and Efficacy

Clinical trials have shown that iDose TR effectively lowers IOP, with results comparable to daily eye drops. The sustained-release mechanism ensures consistent medication delivery, which may lead to better long-term control of glaucoma.

Who Can Benefit from iDose TR?

iDose TR is primarily aimed at patients with open-angle glaucoma or ocular hypertension who are seeking a more manageable treatment option. It is especially beneficial for those who struggle with adherence to daily eye drop regimens.

Procedure and Follow-Up

The implantation of iDose TR is a quick, outpatient procedure. After the procedure, patients will need regular follow-ups to monitor their eye health and the implant’s effectiveness.

Safety and Side Effects

iDose TR has been generally well-tolerated in clinical studies. However, as with any medical procedure, there may be risks and side effects, which will be thoroughly discussed with the patient by their ophthalmologist.

Learn More

For more information about iDose TR, consult your ophthalmologist or visit our Contact Us page to schedule a consultation.